TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 305 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,010 | +51.4% | 259,210 | +53.8% | 0.02% | +36.4% |
| Q2 2023 | $2,648 | +10.4% | 168,541 | +15.8% | 0.01% | 0.0% |
| Q1 2023 | $2,398 | +16.6% | 145,515 | +10.4% | 0.01% | +10.0% |
| Q4 2022 | $2,056 | -99.9% | 131,766 | +10.3% | 0.01% | +11.1% |
| Q3 2022 | $1,549,000 | -6.0% | 119,410 | +1.8% | 0.01% | -10.0% |
| Q2 2022 | $1,647,000 | +3.2% | 117,301 | +5.2% | 0.01% | +11.1% |
| Q1 2022 | $1,596,000 | +43.0% | 111,450 | +36.1% | 0.01% | +28.6% |
| Q4 2021 | $1,116,000 | -23.7% | 81,880 | -8.3% | 0.01% | -30.0% |
| Q3 2021 | $1,463,000 | +9.2% | 89,333 | +12.2% | 0.01% | 0.0% |
| Q2 2021 | $1,340,000 | -14.8% | 79,630 | -7.5% | 0.01% | -28.6% |
| Q1 2021 | $1,572,000 | -1.3% | 86,108 | -1.6% | 0.01% | -30.0% |
| Q4 2020 | $1,592,000 | -1.2% | 87,474 | -3.1% | 0.02% | -16.7% |
| Q3 2020 | $1,611,000 | +3.3% | 90,313 | +3.9% | 0.02% | -14.3% |
| Q2 2020 | $1,559,000 | +83.6% | 86,938 | +55.5% | 0.03% | +47.4% |
| Q1 2020 | $849,000 | +19.9% | 55,909 | +55.7% | 0.02% | +35.7% |
| Q4 2019 | $708,000 | +0.3% | 35,905 | -12.5% | 0.01% | -17.6% |
| Q3 2019 | $706,000 | +13.3% | 41,054 | +16.7% | 0.02% | 0.0% |
| Q2 2019 | $623,000 | -45.3% | 35,172 | -41.5% | 0.02% | -29.2% |
| Q1 2019 | $1,139,000 | – | 60,097 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |